UK healthtech company 01Health has raised $15 million in Series A funding to support the rollout of its healthcare platform across the UK and expand its operations in the United States. The round was led by Gresham House Ventures, with follow-on participation from existing investors Balderton Capital, Eka Ventures, and Wavemaker360, alongside angel investors including Blockchain.com co-founder Nicolas Cary.
Founded in 2022 by former NHS doctor Dr Sonia Szamocki, 01Health develops technology that enables local clinics to provide specialist healthcare services that have traditionally been concentrated in hospitals and larger urban centres. The company was established to address barriers to accessing specialist care, including workforce shortages, geographic constraints, and infrastructure limitations.
To support this approach, the 01Health platform combines specialist oversight, clinical protocols, patient communication tools, operational workflows, and AI-powered patient acquisition into a single system that enables specialist services to be delivered through local clinics.
The technology has so far been used primarily within 01Health's own healthcare services, including the orthodontics platform 32Co and dental sleep medicine provider Aerox Health. Through 32Co, the company has built a nationwide network of providers offering specialist orthodontic treatment across the UK, serving as an early application of the platform.
While 01Health initially focused on dentistry, the platform has been developed to support a broader range of healthcare specialities, with trials already underway in additional clinical areas beyond dental care.
The new funding will support the commercial launch of the 01Health platform as a standalone offering, allowing practices, clinic groups, and dental service organisations to license and deploy the technology directly.
As part of this rollout, the company is introducing the platform publicly for the first time as infrastructure that supports the delivery of specialist care while maintaining clinical oversight and operational consistency.
The funding will also be used to support the company's expansion into the United States.
Would you like to write the first comment?
Login to post comments